Reports Q4 net income 52c per diluted share and CAD 53c per share. “NREF continues to produce consistent earnings while strategically deploying capital across a diversified portfolio of high-quality real assets. Our disciplined approach to capital allocation-spanning life sciences, multifamily, self-storage, and industrial-reflects delivering durable, risk-adjusted returns to our shareholders. As we expand into sectors underpinned by strong demographic and structural demand trends, we remain focused on positioning NREF to capitalize on market dislocations, grow book value, and provide investors with a clear and consistent view of our earnings trajectory and long-term value creation strategy,” said Matthew McGraner, Chief Investment Officer.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NREF:
